Crown Agents better not to take part in medicine procurement next year – MP Bohomolets
Britain's Crown Agents should not take part in international medicine procurement for Ukraine next year, as the company purchases medicines not from pharmaceutical producers, but intermediaries, Head of the parliamentary committee for healthcare Olha Bohomolets said at a briefing on Monday.
"I think that Crown Agents has made two serious mistakes. The first mistake is that there is a delay with supplies of cancer medicines for children and the second gross mistake is that the law on international procurement says that the organizations that are permitted to supply medicines to Ukraine are to buy them from manufacturers, not intermediaries. Crown Agents did not buy medicines from manufacturers. It bought them from the intermediaries that earlier sold medicines to Ukraine. In my opinion, the issue should be discussed and changes should be made not allowing this organization to participate in procurement tenders next year," she said.
Advertising
Advertising
MORE ABOUT
Bohomolets: Martynenko did everything to make Ukraine better
21:05, 29.05.2024
Suppliers of Crown Agents do not revise prices for drugs purchased with state budget due to war
19:19, 02.05.2022
Crown Agents will buy COVID vaccine for Ukraine for EIB loan funds
17:48, 04.11.2021
Health ministry must approve model for calculating cost of healthcare services
18:40, 22.08.2017
Successful healthcare reform should base on mandatory medical insurance, high expenses on healthcare
11:41, 19.07.2017
LATEST
Russia's National Wealth Fund could be depleted within 1 year if oil prices fall to $45-$47 per barrel – Ukrainian diplomat
12:24, 12.03.2025
Ukrainian stocks surge Wed morning following Ukraine-U.S. talks in Jeddah
11:53, 12.03.2025
Rebuilding Ukraine steel capacity hinges on security guarantees – CEO of Metinvest
20:43, 11.03.2025
Some Ukrainian cities face severe challenges next heating season – expert
20:32, 11.03.2025
Finance Ministry raises market govt loan bond rates by 0.5 pp following 1 pp increase in accounting rate